Sanjay Chanda An2 Therapeutics, Inc. (ANTX) insider trading activity

ANTX Quotes by TradingView

Sanjay Chanda is Chief Development Officer of AN2 Therapeutics, Inc.. Currently has a direct ownership of 75,823 shares of ANTX, which is worth approximately $86,438. The most recent transaction as insider was on Jan 06, 2026, when has been sold 5,956 shares (Common Stock) at a price of $1.01 per share, resulting in proceeds of $6,015. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.8K
5.31% 3M change
154.23% 12M change
Total Value Held $86,438

Sanjay Chanda Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2026
SELL
Open market or private sale
$6,015 $1.01 p/Share
5,956 Reduced 7.28%
75,823 Common Stock
Jan 05 2026
SELL
Open market or private sale
$3,295 $1.0 p/Share
3,295 Reduced 3.87%
81,779 Common Stock
Feb 26 2025
BUY
Grant, award, or other acquisition
-
50,250 Added 38.56%
80,074 Common Stock
Jan 03 2025
SELL
Open market or private sale
$3,962 $1.34 p/Share
2,957 Reduced 9.02%
29,824 Common Stock
Mar 15 2024
BUY
Grant, award, or other acquisition
-
27,500 Added 49.34%
28,235 Common Stock
SC

Sanjay Chanda

Chief Development Officer
Menlo Park, CA

Track Institutional and Insider Activities on ANTX

Follow AN2 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANTX shares.

Notify only if

Insider Trading

Get notified when an An2 Therapeutics, Inc. insider buys or sells ANTX shares.

Notify only if

News

Receive news related to AN2 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ANTX